No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
REGN241220C740000
- 7.07
- -21.73-75.45%
15min DelayClose Dec 13 16:00 ET
10.70High7.07Low
8.25Open28.80Pre Close18 Volume2 Open Interest740.00Strike Price15.34KTurnover35.27%IV2.16%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry7.07Extrinsic Value100Contract SizeAmericanOptions Type0.3951Delta0.0133Gamma92.57Leverage Ratio-1.3163Theta0.0352Rho36.57Eff Leverage0.3151Vega
Intraday
- 5D
- Daily
News
BofA Restarts Coverage of 11 Large-cap Biopharmas
Piper Sandler Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,195
Regeneron Pharmaceuticals (REGN): Sales Struggles and Future Prospects
B of A Securities Reinstates Underperform on Regeneron Pharmaceuticals, Announces $565 Price Target
Regeneron Pharmaceuticals Analyst Ratings
Regeneron Presents New And Updated Data For Odronextamab At ASH Annual Meeting